Antibiotic neutralization |
Enzymes produced by microbes to modify/degrade antibiotic; rendering it inactive |
β-lactam degradation and aminoglycoside modifications (Wright 2005); metallo-β-lactamase, and aminoglycoside acetyltransferase in A. baumannii
|
Presumably yes as enzyme induction requires RNA and protein synthesis utilizing iron dependent enzymes |
Antibiotic target modification |
Mutations providing altered non-sensitive microbial target |
Mupirocin resistance in S. aureus from altered insensitive isoleucine-tRNA synthetase target (Liu et al. 2017) |
Presumably yes as low iron can suppress Fe-dependent ribonucleotide reductase levels as needed for DNA synthesis and repair |
Antibiotic Efflux Pumps |
Reduced intracellular antibiotic concentration, exclusion from cell |
Ciprofloxacin and other fluoroquinolone efflux in P. aeruginosa (Lubelski et al. 2007; Amaral et al. 2014) |
Yes, iron withdrawal can affect energy production by iron-dependent enzymes and iron insufficiency causes membrane instability (Prasad et al. 2006) |
Physical resistance to antibiotic delivery into microbes |
Biofilm growth physically protecting microbes within biofilm |
P. aeruginosa biofilm displays resistance (Gupta et al. 2016) |
Yes, iron withdrawal can suppress biofilm formation and also disrupt established biofilm growth (Post et al. 2019) |
Metabolic mutation; persister cells |
Slower growth and reduced electron transport reduces antibiotic sensitivity |
S. aureus small colony variants—hemin/menadione and thymidine auxotrophs display multiple resistance (Proctor et al. 1998, 2014) |
Yes, deferiprone-Gallium active against S. aureus SCVs, particularly hemin auxotrophs (Richter et al. 2017) |